Invention Grant
US08314092B2 Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists
有权
取代的[（5H-吡咯并[2,1-c] [1,4]苯并二氮杂-11-基）哌嗪-1-基] -2,2-二甲基丙酸化合物作为双活性H1反向激动剂/ 5-HT2A拮抗剂
![Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists](/docs/US/2012-11-20/US08314092B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists
- Patent Title (中): 取代的[（5H-吡咯并[2,1-c] [1,4]苯并二氮杂-11-基）哌嗪-1-基] -2,2-二甲基丙酸化合物作为双活性H1反向激动剂/ 5-HT2A拮抗剂
-
Application No.: US13357627Application Date: 2012-01-25
-
Publication No.: US08314092B2Publication Date: 2012-11-20
- Inventor: Anne Marie Camp , Peter Thaddeus Gallagher , Andrew James Ledgard , Adam Jan Sanderson , David Andrew Coates
- Applicant: Anne Marie Camp , Peter Thaddeus Gallagher , Andrew James Ledgard , Adam Jan Sanderson , David Andrew Coates
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent R. Craig Tucker
- Main IPC: A61P25/20
- IPC: A61P25/20 ; A61K31/5517 ; C07D487/04
![Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists](/abs-image/US/2012/11/20/US08314092B2/abs.jpg.150x150.jpg)
Abstract:
A dual H1/5-HT2A receptor antagonist of the formula: its uses, and methods for its preparation are described.
Public/Granted literature
Information query
